2-(Pyridin-3-yl)pyrimidine-5-carbonitrile

Catalog No.: 
ACLPAR022
CAS No.: 
101688-01-1
Molecular Formula: 
C10H6N4
Molecular Weight: 
182.19
2-(Pyridin-3-yl)pyrimidine-5-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$417.00InquiryInquiry
100mg95%$613.00InquiryInquiry
250mg95%$866.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Pyridin-3-yl)pyrimidine-5-carbonitrile
IUPAC Name2-(pyridin-3-yl)pyrimidine-5-carbonitrile
MDL No.MFCD11840225
Molecular FormulaC10H6N4
Molecular Weight182.19
SMILESN#CC1=CN=C(C2=CC=CN=C2)N=C1
InChI KeyBRUQDTPKOZAXAU-UHFFFAOYSA-N
Synonym2-(PYRIDIN-3-YL)PYRIMIDINE-5-CARBONITRILE;5-Pyrimidinecarbonitrile, 2-(3-pyridinyl)-
CAS No.101688-01-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACLPAR022 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGOVS347 route compound structure diagram
    ACGOVS3471753-50-0In Stock
  2. Plus
  3. ACPGVQ689 route compound structure diagram
    ACPGVQ6891692-25-7In Stock
  4. Then
  5. ACLPAR022 route product structure diagram
    ACLPAR022101688-01-1
Inquiry

2. ACLPAR022 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1In Stock
  4. Then
  5. ACLPAR022 route product structure diagram
    ACLPAR022101688-01-1
Inquiry

3. ACLPAR022 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLPAR022 route product structure diagram
    ACLPAR022101688-01-1
Inquiry

Comments (0)